首页> 美国卫生研究院文献>Computational and Structural Biotechnology Journal >DeepOmix: A scalable and interpretable multi-omics deep learning framework and application in cancer survival analysis
【2h】

DeepOmix: A scalable and interpretable multi-omics deep learning framework and application in cancer survival analysis

机译:DeepOmix:可扩展和可解释的多OMICS深度学习框架和癌症生存分析的应用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Integrative analysis of multi-omics data can elucidate valuable insights into complex molecular mechanisms for various diseases. However, due to their different modalities and high dimension, utilizing and integrating different types of omics data suffers from great challenges. There is an urgent need to develop a powerful method to improve survival prediction and detect functional gene modules from multi-omics data. To deal with these problems, we present DeepOmix (a scalable and interpretable multi-Omics Deep learning framework and application in cancer survival analysis), a flexible, scalable, and interpretable method for extracting relationships between the clinical survival time and multi-omics data based on a deep learning framework. DeepOmix enables the non-linear combination of variables from different omics datasets and incorporates prior biological information defined by users (such as signaling pathways and tissue networks). Benchmark experiments demonstrate that DeepOmix outperforms the other five cutting-edge prediction methods. Besides, Lower Grade Glioma (LGG) is taken as the case study to perform the prognosis prediction and illustrate the functional module nodes which are associated with the prognostic result in the prediction model.
机译:多OMICS数据的综合分析可以阐明对各种疾病的复杂分子机制的有价值的见解。然而,由于它们不同的方式和高维度,利用和整合不同类型的OMICS数据遭受了极大的挑战。迫切需要开发一种强大的方法来改善生存预测,并检测来自多OMICS数据的功能基因模块。为了应对这些问题,我们呈现DeepOmix(可扩展和可解释的多OMICS深度学习框架和癌症生存分析中的应用),一种灵活,可扩展和可解释的方法,用于提取临床生存时间与基于多OMICS数据之间的关系在深度学习框架上。 DeepOmix使得来自不同OMIC数据集的变量的非线性组合,并包含用户定义的先前生物信息(例如信令路径和组织网络)。基准实验表明DeepOmix优于其他五个尖端预测方法。此外,较低等级的胶质瘤(LGG)被认为是执行预后预测的案例研究,并说明与预测模型中的预后结果相关联的功能模块节点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号